Mach-1 Financial Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-23,228
Closed -$376K 165
2023
Q4
$376K Sell
23,228
-11,701
-33% -$191K 0.14% 165
2023
Q3
$430K Buy
34,929
+4,388
+14% +$65.3K 0.18% 156
2023
Q2
$491K Buy
+30,541
New +$503K 0.14% 150

Other funds holding NEO

Mach-1 Financial Group's NEO Position: Q1 2024 in Review

Mach-1 Financial Group sold out of NeoGenomics (NEO) in Q1 2024, closing a stake of 23,228 shares — an estimated $376K sold.

Mach-1 Financial Group first reported a position in NEO in Q2 2023 and held it in 3 quarters. The position peaked at $491K in Q2 2023. 263 funds tracked by Wall St. Rank hold NEO as of Q1 2024.

  • Mach-1 Financial Group reported no remaining NeoGenomics position as of Q1 2024 after selling out during the quarter.
  • Mach-1 Financial Group sold 23,228 NeoGenomics shares in Q1 2024, an estimated $376K.
  • Mach-1 Financial Group first reported a position in NeoGenomics in Q2 2023 and held it in 3 quarters.
  • Mach-1 Financial Group's NeoGenomics position peaked at $491K in Q2 2023.
  • 263 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2024.

Based on Mach-1 Financial Group's 13F filing for Q1 2024, filed 10 May 2024.